Orgenesis Inc logo

Orgenesis Inc Share Price (NASDAQ: ORGS)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 1 Nov 2024

Check the interactive Orgenesis Inc Stock chart to analyse performance

Orgenesis Inc Key Stats

Check Orgenesis Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.0
Open
$1.24
Market Capitalization
$5.7M
Today's Volume
$10.3K
Revenue TTM
$662.0K
EBITDA
$-19.1M
Earnings Per Share (EPS)
$-8.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-727.25%

Global Institutional Holdings in Orgenesis Inc

  • Name

    Holdings %

  • Vanguard Group Inc

    1.91%

  • Geode Capital Management, LLC

    0.59%

  • BlackRock Inc

    0.17%

  • State Street Corp

    0.17%

  • Northern Trust Corp

    0.08%

  • Bank Hapoalim BM

    0.07%

Analyst Recommendation on Orgenesis Inc Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Orgenesis Inc(by analysts ranked 0 to 5 stars)

About Orgenesis Inc

Orgenesis Inc., a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. The company also provides development services, including regulatory services, pre-clinical studies, intellectual property services, and GMP process translation, as well as support services; hospital services; cell process development services; and distributed cell processing services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland.
Organization
Orgenesis Inc
Employees
146
CEO
Ms. Vered Caplan M.Sc.
Industry
Health Technology

Important FAQs about investing in ORGS Stock from India :

What is Orgenesis Inc share price today?

Orgenesis Inc share price today is as on at the close of the market. Orgenesis Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Orgenesis Inc share?

Orgenesis Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Orgenesis Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Orgenesis Inc Stock (ORGS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Orgenesis Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Orgenesis Inc Shares .

What is the minimum amount required to buy Orgenesis Inc Stock (ORGS) from India?

Indian investors can start investing in Orgenesis Inc (ORGS) shares with as little as ₹90.217 or $1 (as of January 11, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹902.17 in Orgenesis Inc stock (as per the Rupee-Dollar exchange rate as on January 11, 2026). Learn more about fractional shares .

What are the returns that Orgenesis Inc has given to Indian investors in the last 5 years?

Orgenesis Inc stock has given 0.0% share price returns and 22.79% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?